Semaglutide Does Not Increase Psychiatric Complications in Overweight, Obesity

Follow Drugslib on

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

TUESDAY, Sept. 3, 2024 -- Treatment with semaglutide does not increase the risk for developing symptoms of depression or suicidal ideation/behavior among adults with overweight or obesity, according to a study published online Sept. 3 in JAMA Internal Medicine.

Thomas A. Wadden, Ph.D., from the Perelman School of Medicine at the University of Pennsylvania in Philadelphia, and colleagues examined the psychiatric safety of subcutaneous semaglutide, once weekly, among people without known major psychopathology in a post-hoc analysis of pooled data from the multicenter, phase 3a STEP 1, 2, and 3 trials (3,377 participants) and phase 3b STEP 5 trial (304 participants), which included adults with overweight or obesity.

The researchers found that in the STEP 1, 2, and 3 trials, the mean baseline Patient Health Questionnaire (PHQ-9) scores were 2.0 and 1.8 for semaglutide and placebo, respectively, and the mean scores at week 68 were 2.0 and 2.4, respectively. Patients receiving semaglutide versus placebo were less likely to shift to a more severe category of PHQ-9 depression from baseline to week 68 (odds ratio, 0.63). Overall, 1 percent or fewer participants reported suicidal ideation/behavior during treatment based on the Columbia-Suicide Severity Rating Scale; no differences were seen between the semaglutide and placebo groups. Results were similar in STEP 5.

"Our new analyses provide assurance that the medication, when taken by individuals who are free of significant mental health concerns, does not increase the risk of depression, suicidal thoughts, or suicidal behavior," Wadden said in a statement.

Several authors disclosed ties to pharmaceutical and weight loss companies, including Novo Nordisk, which manufactures semaglutide and funded the study.

Abstract/Full Text

Editorial (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-09-04 15:22

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords